top of page
Board of Directors
Bob.png
Co-Founder, Contour
Venture Partners
BOB GREENE
LI-In-Bug.png

Bob Greene is a co-founder of Contour Venture Partners. He has invested in all stages of venture capital across several industry sectors. Contour invests in early stage companies focused on information technology and the application of technology into the financial services, enterprise SaaS and digital media sectors. Bob’s investments include BounceX, Covr, Dstillery, Fevo, Pathgather, Punchbowl, Radius Networks, Scripta, Simpli.fi, Slice, Source3, SwapDrive, Syndio, Trialjectory and Voxy.

 

Prior to launching Contour in 2006, Bob was one of the three managing partners of Flatiron Partners in New York City. The firm backed more than 50 companies with over $500 million of venture capital. Bob received a BS from the Wharton School of Business and an MBA from the MIT Sloan School of Management.

Avery.png
Investment Professional
AVERY KLINGER
LI-In-Bug.png

Avery Klinger is an investment professional at Aquiline Capital Partners, a New York and London based private investment specialist focused on financial services and technology. Within his role, Avery leads the healthcare & benefits strategy for the firm’s venture fund. He currently holds board roles with Ideon, Valera Health and LegalMation and is active in supporting 20+ current investments across Aquiline’s portfolio.

 

Prior to joining Aquiline, Avery worked as an investment banker at Cain Brothers, a division of KeyBanc Capital Markets, where he focused on advising growth-stage companies in the healthcare technology, healthcare services and insurance industries. He holds a B.A. in both Economics and Spanish from Hamilton College.

Executive Chairman,
Scripta Insights
SANDERS PITMAN
LI-In-Bug.png

Sanders "Sandy" Pitman is Executive Chairman at Scripta Insights, an Eastside portfolio company. He joins Scripta with more than 35 years in the healthcare IT space as an experienced CEO, operator and investor. 

 

Sandy is also a Venture Partner at Eastside Partners where he has been a limited partner in each Eastside fund and its predecessor funds (SETFUND) since 1998. He co-invests in portfolio companies, provides board member services and strategic guidance, and conducts day-to-day management as needed.

Sandy has served as President at ProctorU, an online proctoring service for academic exams and professional certifications; President at HYGIA Health Services, a re-processor of certain single-use, non-invasive medical devices; and CEO at SuccessEHS, a vendor providing Electronic Health Record (EHR) and Practice Management solutions with Integrated Medical Billing Services. He earned a Bachelor of Business Administration degree from the University of Alabama.

SandersPitman.png
Senior Lecturer of Business Administration, Harvard Business School
SATISH TADIKONDA
LI-In-Bug.png

Satish Tadikonda is a Senior Lecturer in the Entrepreneurial Management Unit at Harvard Business School and a serial entrepreneur in the life sciences and healthcare sectors. His main interests lie in Healthcare IT and at the intersection of drug, medical device and diagnostics development, and software systems development, primarily for accelerating clinical trials and regulatory approvals.

 

Satish’s current venture, Trove Health, focuses on building technology for the engagement and retention of patients in clinical trials. Prior to Trove Health, he founded a number of companies in the life sciences software space.

 

Satish currently serves on the Board of Directors of Scripta Insights, ConnectM Technologies, Gradient Health and Gateway for Cancer Research. He is also an Executive Advisor to Blue Cloud Ventures and an Advisor to Two Lantern Ventures.

​

Satish is a very active early-stage investor as a member of TiE Angels and member and co-founder of TiE ScaleUp, an accelerator focused on scaling seed and Series A companies. He was also an active participant in helping develop drug and medical device industry standards, and has published several articles in peer-reviewed journals on various medical imaging technology topics.

​

Satish holds a Doctorate in Electrical and Computer Engineering, with a focus on medical imaging, from the University of Iowa, and a Bachelor’s in Electrical and Electronics Engineering from the Birla Institute of Technology and Science (Pilani).

SATISH@300x.png
Board of Advisors
Sharon@300x.png
Chief Development Officer, Lane Health
SHARON
CUNNINGHIS
LI-In-Bug.png

Sharon Cunninghis is Chief Development Officer at Lane Health, a new disrupter focused on improving health by eliminating financial barriers to care that often lead to negative outcomes.

 

Her role includes development of strategies and plans for acquiring new customers, and she is involved in business strategy, operations, member services and sales. Prior to joining Lane Health, she spent most of her career at Mercer, a leading human resources consulting firm, where she was most recently the US Health Leader, and led the development of Mercer Marketplace 365 beforehand.

 

She holds a B.S. in Economics from The Wharton School at University of Pennsylvania, where she graduated Cum Laude. She is an Associate of the Society of Actuaries and was named a Top 25 Consultant by Consulting Magazine in 2013.

Scripta_Logo_NavigationTag_White.png

40 Grove St, Suite 270
Wellesley, MA 02482

info@scriptainsights.com

  • LinkedIn - White Circle
  • YouTube - White Circle

MEMBER SUPPORT:

DOWNLOAD THE FREE SCRIPTA  MEMBER APP

google-play-badge_English_edited.png

© Copyright Scripta Insights, Inc. 

Scripta™ is neither a pharmacy nor a doctor. The benefit service does not tell you what drug to take and does not participate in the drug selection process. Only your physician can determine the medications that are right for you. These alternative medications are options for less costly drugs that physicians may prescribe in place of the medications you are taking now. Scripta has reviewed your current medications only for the purpose of identifying potential cost savings for you to consider with your physician. Scripta has not analyzed the effectiveness or other therapeutic aspects of these medication alternatives. Accordingly, this report and any other forms of communication received from Scripta are not, nor should they be interpreted as, any form of treatment, drug regimen review, or provision of counseling or consultation by a prescriber, pharmacist or pharmacy. Do not stop taking your medication, change your medication, or start taking a new medication without being directed to do so by your physician and filling the prescription under the oversight of a licensed pharmacist. The alternatives set forth above may not be equivalent to your current medication, may interact adversely with your other medications, may not be indicated in light of your other conditions, may cause different or severe side effects, or may be less effective at treating your condition. Medication prices are approximate based on information provided by your pharmacy benefits manager, insurance plans, and/or employer, and may vary from pharmacy to pharmacy. Check with your insurance plan to obtain a full list of pharmacies where your prescriptions can be filled. All information herein is HIPAA protected, treated as highly confidential, and never shared with your employer.

​

Scripta™, Scripta Insights™ and The Best Meds at the Best Price® are registered trademarks of Scripta Insights, Inc. The contents of the site are for informational purposes only and not intended as a substitute for professional medical advice, diagnosis, or treatment. We do not recommend or endorse any specific prescription drug or pharmacy that may be mentioned herein. Reliance on any information provided by us, our affiliates, employees or others is solely at your own risk.

bottom of page